Marijuana Today Daily Headlines
Wednesday, August 26, 2020 | Curated by host Shea Gunther
// Congressman Raising Money To Legalize Psychedelic Mushroom Therapy (Marijuana Moment)
// MindMed Plans MDMA-LSD Trial To Study ‘Bad Trip’ Reduction (Green Market Report)
These headlines are brought to you by Curaleaf, one of the leading vertically-integrated cannabis operators in the U.S. With legal medical and adult use marijuana dispensaries, cultivation sites, and processing facilities all over the United States, Curaleaf has served more than 350,000 medical cannabis patients and looks forward to helping many more long into the future. Swing over to Curaleaf.com to learn more about this very cool company!
// Ascend Wellness completes $68 million raise, acquires Illinois marijuana shops (Marijuana Business Daily)
// Marijuana Sales Are ‘Pandemic-Proof,’ Top Illinois Cannabis Regulator Says (Marijuana Moment)
// Lawmakers poised to pass expansion of marijuana expungements (VT Digger)
// TILT Holdings Q2 Revenue Slips 9% from Q1 to $38.6 Million (New Cannabis Ventures)
// Hexo Molson Coors launch Truss cannabis beverage portfolio (Marijuana Business Daily)
// Chart: Nationwide sales of adult-use cannabis further eclipse those of medical marijuana (Marijuana Business Daily)
Check out our other projects: • Marijuana Today— Our flagship title, a weekly podcast examining the world of marijuana business and activism with some of the smartest people in the industry and movement. • Marijuana Media Connect— A service that connects industry insiders in the legal marijuana industry with journalists, bloggers, and writers in need of expert sources for their stories.
Love these headlines? Love our podcast? Support our work with a financial contribution and become a patron.
Photo: Governor Tom Wolf/Flickr
As the COVID-19 pandemic continues to spread, with the death toll and reported cases rising each day, quarantines and impeding restrictions have sent consumers rushing to stores to stock up and panic-buy everything from antiseptic wipes to toilet paper to meat, and now cannabis. While the viral videos of shoppers going rockem socket for Purex […]
Spain’s foremost cannabis activist is a 76-year-old woman in the southern province of Málaga who has been asserting her right to home cultivation for over a generation now. Fernanda de la Figuera — ubiquitously known as Abuela Marijuana, or Grandma Marijuana — has been busted before, and won a landmark ruling in her favor from the Spanish courts.
In spite of this, she was busted again, and this time convicted and sentenced. But now she says she will appeal to the European Union’s highest judicial body.
On Jan. 30, a Málaga judge convicted de la Figuera of drug trafficking, on the basis of a 2014 raid on her home in the small town of Alhaurín el Grande by a contingent of the Civil Guards, Spain’s militarized national police force. The raid turned up her backyard garden of some 180 cannabis plants.
Prosecutors asked for four years’ imprisonment. The judge gave a sentence of just nine months — which is below the two-year threshold for mandatory prison time. This means she could likely receive a suspended sentence and escape actually going to jail, if she confesses to her “crime” and commits no second offense during the nine months.
But de la Figuera isn’t having it. She insists she was growing for her own personal use, and her collective of medical users, and that she has the right to do so — already upheld by the Spanish courts. She told local media that she will now take her case to a higher authority — the European Court of Human Rights, in Strasbourg, France.
’Apostle of Homegrown’ Won’t Accept Deal
De la Figuera considers herself the “apóstol del autocultivo” — the apostle of homegrown. She smoked cannabis for the first time in Paris in the ’60s, and found that it relieved the epilepsy and rheumatism she had been struggling with since childhood. She has been growing the plant since 1973, and won her ground-breaking legal victory recognizing her right to do so more than 20 years later.
In 1995, her same home in Alhaurín el Grande was raided, and she was brought up on cultivation charges. But the judge dismissed the charges on individual liberty grounds. Abuela Marijuana boasted that she’d become the first legal cannabis cultivator in Spain.
The quantity in the case was considerably lesser than the 180 plants in the 2014 bust. But in the intervening years, she had founded MaríasXMaría (Marias for Maria), an “association” of women from across Spain’s southern Andalusia region suffering from arthritis, fibromyalgia and other ailments they treat with cannabis. She insisted that her cultivation was “therapeutic work,” for members of the association.
And in 2015, Spain passed a law expanding on its 1983 decriminalization of cannabis, allowing personal cultivation — provided it is hidden from public view. However, it is uncertain this could apply in de la Figuera’s case, both because it would have to be retroactive and because of the quantities involved. Additionally, it is unclear if backyard cultivation clearly counts as hidden from the public.
De la Figuera considers the charge against her transparently bogus. “The judge in my town knows that all my life I’ve made my living in the real estate market, and that I don’t dedicate myself to selling marijuana,” she told Andalusia’s El Diario newspaper. “This is not my interest, but to make known this wonderful substance, and how good it is for the health of many people.”
The 2015 law was designed to protect Spain’s cannabis associations. But an unfavorable ruling of the country’s Supreme Court in 2018 imposed strict conditions on such associations, barring them from most public activity and making them nearly impossible to function legally.
Rather than appealing within the Spanish judicial system, de la Figuera announced after the verdict that she intends to bring the case directly to the European Court of Human Rights, where a ruling could set a precedent for the entire European Union.
From Málaga to Strasbourg
Grandma Marijuana just may have the savvy to pull it off. In addition to being a skilled cultivator and medical provider, she is an activist of long years’ experience. In 1995, after her historic court ruling, she founded the Cannabis Party for Legalization and Normalization (PCLYN), Spain’s first national political party dedicated to marijuana liberation.
The following year, she founded the Ramón Santos Association for the Study of Cannabis in Andalusia (ARSECA), named after a late criminal defense attorney who defended many cultivators in the region and dedicated to documenting the medical benefits of the herb.
And MaríasXMaría is a member of another national organization she helped found, the Federation of Cannabis Associations (FAC). She’s also involved in the Action Group for the Legalization of Cannabis in Spain (GALCE), and its affiliated website, Infocannabis.
And she has taken her work to the continental level, as Spain representative of the European Coalition for Just and Effective Drug Policies (ENCOD).
When her new case was still pending late last year, de la Figuera won an important symbolic victory, at least, when her province’s ruling left-wing coalition, Adelante Málaga, came out unequivocally and publicly in her support, with provincial councilors posing alongside her in a photo op.
Her case may soon have an impact that will resonate across the European continent.
TELL US, do you think it should be legal to grow your own pot?
Cannabidiol (CBD) is the most dominant, non-psychoactive cannabinoid found in the cannabis plant, and the methods for utilizing this compound are becoming increasingly technical.
When it comes to products other than flowers, the CBD needs
to be extracted from the plant matter and processed into isolate or distillate.
If you’re trying to manufacture a product with a very specific amount of CBD in
it – medication for example that would require accuracy down to the milligram –
you will need isolate or distillate.
But not just any CBD isolate or distillate will be acceptable though, you will need it to be made at a EU GMP facility. This applies to anyone in the world, as the industry is moving towards a more regulated entity, but GMP (good manufacturing practice) is especially important in the European CBD/hemp industry.
All European cosmetics and medications that have CBD (and otherwise) in them need to be GMP-certified and listed in the Eudra Database, which will cover a bit more later in the article. For now, let’s take a look at the difference between CBD distillate and isolate.
We also have a B2B deal listed at the end of the post for EU GMP CBD distillate and isolate. Both products will be sold in large orders (kilos) and can be used for the manufacture of legal CBD products to distribute throughout Europe and the rest of the world.
Looking for certified EU GMP CBD isolate or distillate?
Click HERE or use the sign-up form below to subscribe to the CBD Business Weekly Newsletter.
What is CBD?
Cannabidiol, or CBD, is a non-psychoactive compound found in the
cannabis plant. It’s also the second most prominent cannabinoid, next to
tetrahydrocannabinol (THC), that most people are relatively familiar with.
CBD can be extracted from both regular cannabis plants (those
with all cannabinoids including THC, and often what you’d find in a medical
cannabis dispensary and recreational store) and hemp plants (classified as
having less than 0.3 percent THC content and often used for more industrial
purposes). When talking about CBD extracts, there are a few terms that
frequently get thrown around: isolate, broad
spectrum, and full spectrum, we’ll discuss the difference shortly.
Numerous studies showing the medical potential of CBD have been making
the headlines in recent years. It’s been used to treat epilepsy, chronic
pain, inflammation, anxiety, depression,
and more. It’s used therapeutically much more often than THC (tetrahydrocannabinol)
because it doesn’t have any mind altering effects.
The reason CBD works for such
a diverse range of conditions is because of the Endocannabinoid
System (ECS). The ECS is a network of receptors that can be found throughout
the bodies of all mammals. We naturally create cannabinoids which bond to these
receptors to regulate different processes in our bodies and maintain
The ECS helps manage
things such as immune function, appetite, sleep wake cycles, pain response, and
the list goes on.
On the other hand, when
we are ‘cannabinoid
deficient’ our bodies become destabilized and no longer function
optimally. It’s theorized that many illnesses stem from the inability to produce
endocannabinoids. This is where supplementing with plant-based cannabinoids
(phytocannabinoids) comes into play.
The Difference Between CBD Isolate and Distillate
most CBD extract on the market is isolate. As the name indicates, this product
is made by completely isolating the cannabidiol from all the other plant matter
and compounds. That means all other cannabinoids, terpenes, flavonoids, and inactive
compounds are stripped from the extract, leaving only CBD. The final product is
a fine white powder that has over 99% CBD. Basically, it’s an extra-refined
Because it’s odorless, tasteless, and highly concentrated, it’s a great to use in the manufacture of many medical, wellness, and retail products. Its purity means that 1 milligram of isolate equals exactly 1 milligram of CBD, whereas 1 milligram of less potent extract might have 0.5 milligrams of CBD, 0.3 milligrams of CBG, and 0.2 combination of other terpenes and compounds. This makes isolate very easy to use for specific dosing.
Distillate is another highly concentrated cannabis extract. CBD distillate typically has upwards of 90% cannabidiol, but because it’s created differently than isolate, it retains a bit more of its other compounds. Distillate is good for anyone who needs accurate dosing, but could stand to benefit from the Entourage Effect as well.
To make isolate, the CBD must be extracted from the plant – and
there are numerous ways to do this. The industry gold standard and consumer
favorite is CO2 extraction. The equipment is industrial and very pricey, but
this method results in a very pure final product. A closed-loop system is used
to cool CO2 to -56C, as the pressure inside the chamber is hiked up to 75psi.
The CO2 becomes “supercritical” at this stage and sits somewhere
between a liquid and gaseous state. The CO2 is then passed through the closed
chamber and, almost like a solvent, the cannabinoids and terpenes are extracted
and remain intact. This process is called Supercritical CO2 Extraction. There’s
also Subcritical CO2 Extraction which used cheaper equipment, lower pressure,
and results in smaller yields.
A more cost-efficient but equally effective method is with an ethanol extraction system. Ethanol extraction involves applying the solvent ethanol directly to the hemp plant in order to extract the cannabinoids. Ethanol extraction has gotten a bad reputation as being unsafe, but that’s simply incorrect. Ethanol extraction is actually an FDA-approved method of extraction compounds from various plants in order to make food and medicines.
There is one issue with ethanol extraction, however. Certain
compounds easily co-extract with ethanol, and the one of concern here is chlorophyll.
Chlorophyll is a molecule that absorbs sunlight and converts it into plant
energy. It also gives plants their green color. When using ethanol extraction,
the chlorophyll may need to be stripped away in a separate process.
Distillate is a bit different. After CBD is oil extracted from the plant, it’s vaporized and the vapor is collected in a distillation cooling system. Each compound in the plant can be separated because of the variations in volatility, or boiling point, so the result is a relatively clean product.
What Are These Products Used For?
These products can be used to make anything that has CBD in it – edibles, topicals, tinctures, softgels, nasal sprays, various pharmaceuticals, and the list goes on. Anything that requires accurate dosing and will benefit from isolate and distillate.
Better yet, if the product is manufactured in a GMP-certified
facility. It’s already a requirement in Europe, India, and many other
countries/continents that all medications, supplements, and cosmetics must be
GMP-certified. And while the North American market is currently an unregulated
free-for-all, this is expected to change over the next few years.
The Eudra GMDP is the name for the Union database that lists products with GMP certificates as well as current import authorizations. The Eudra database was first launched system in April 2007, with a second release in July 2009. It is maintained and operated by the EMA (European Medicines Agency). Access to this database is granted to the general public in order to educate and inform, and to encourage the compliance of brands and manufacturers.
The public version of the database has been available since 2011. Some information is excluded from the Eudra database such as able to exclude some information from public view. This includes information of a commercially sensitive or personal nature, inspection planning and information that may need to be restricted in the interests of security.
The goal of Eudra is to “improve the sharing of information
between regulators and the public, including the pharmaceutical industry; aid
the coordination of inspections of manufacturers in third countries among
national competent authorities; eliminate the need for industry to submit paper
documents to support marketing-authorisation and variation applications; and help
protect the medicine distribution chain and active-substance supply chain by
facilitating the verification of legitimate actors.”
Where to Get EU GMP CBD Isolate and Distillate
We have partnered with some leading suppliers of CBD isolate and distillate. Both products are, as you probably guessed, GMP and certified by the EU, listed in the Eudra database, and available for export globally. We offer the best pricing and have the ability to accommodate extremely large orders.
EU GMP CBD isolate and distillate
We offer wholesale orders for our subscribers. The pricing for EU GMP CBD Distillate and Isolate is as follows:
- 1 – 25kg – €1,750
- 25 – 50kg – €1,550
- 50 – 100kg – €1,450
- 100kg+ – €1,350
- 1 – 50kg – €5,740
- 50 – 100kg – €5,500
- 100kg+ – Negotiable
The post Your Complete Guide to EU GMP-Certified CBD Isolate and Distillate (European Market) appeared first on CBD Testers.
Sicilian cannabis patients may be celebrating after news dropped yesterday that the region’s medical marijuana supplies would be free to certain qualified program participants. Sicily’s top health administrator Ruggero Razza signed a decree that patients with chronic or neuropathic pain, cerebral palsy, or multiple sclerosis will qualify for the government’s subsidized marijuana.
In so doing, Sicily joins national governments in the EU like Ireland and the Czech Republic who have made the decision to largely pay for some of its population’s cannabis treatments.
According to the Italian system, patients must obtain a prescription for cannabis from a doctor. With that script, they are able to buy cannabis from a licensed pharmacist, which gets its supply from either the Italian ministry of defense or from a list of certified importers.
At the moment, most of Italy’s medical cannabis supplies come from the Netherlands, via the Dutch Office of Medical Cannabis, though the country’s Stabilimento Chimico Farmaceutico di Firenze, an agency within the Department of Defense, is also allowed to produce medicinal cannabis supply. Medical marijuana has been legal in the country since 2013.
Canadian cannabis company Aurora is also one of Italy’s medical suppliers. It was authorized in June to import 400 kilograms into the country over the next two years — though part of that contract was canceled in November. Aurora is a popular choice among EU governments. The brand also has a contract with the government of Luxembourg and supplies one of only three authorized products that will be permitted in Ireland’s medical cannabis system, set to become operational within the next few months.
Sicilian subsidies are not the only recent news in Italy’s quest to widen cannabis access. Last month, the country’s highest court decided that citizens should be able to grow cannabis in their home, and that personal cultivation was not relevant to the criminal persecution of cannabis-related crimes. The court published a December 19 opinion stating that, “at home, small-scale cultivation activities are to be considered excluded from the application of the penal code.”
In so doing, the country joins only a handful of peers that have regulated home cultivation for recreational uses, such as Uruguay.
The court’s home cultivation decision was motivated by cases like that of a Torre Annunziata man who was sentenced to a year of incarceration and 3,000 euros when he was discovered growing a pair of cannabis plants.
CBD in Italy
CBD products — called “cannabis light” locally — are widely available in Italian stores and bring in around 40 million euro a year. Hemp grows well in the Italian climate, even helping to renew soil that has been exhausted by exhaustive wheat cultivation.
But hemp-based products have not escaped controversy, and have come under fire from the country’s conservative political parties. Raids on cannabis light stores last summer resulted in one business owner chaining himself to the doors of his store after it was raided by the police. In response, Italy’s parliament voted to legalize the hemp-based products, but the lawmakers were overruled by the Senate, which denied the plan in December.
As legal battles continue, the country’s scientists have been working to improve our understanding of the drug. Earlier this year, Italian researchers announced the discovery of two new cannabinoids, which they dubbed CBDP and THCP.
The post Medical Marijuana Now Available for Free for Patients in Sicily appeared first on High Times.
Yes, you read that right. We’re
expanding our CBD Testers program to Europe, so we need people to join our list
and get free products.
Now to elaborate a bit, all you need is 15 to 30 minutes to spare each month in exchange for free CBD products. There are numerous benefits not only for you but for the entire industry. First and foremost, you get free products which is always a plus in my book. You’ll be receiving a variety of products including:
- Oil and tinctures for overall health
- Softgels for pain, anxiety, or other ailments
- Topicals for eczema, acne, and more
Most importantly, these free products are all GMP and ISO certified, so they are manufactured in the safest possible way. We only work with products that are legitimate, lab-tested, and approved by the United Hemp Alliance.
Of course, you’re not the only one who benefits from all this. In doing this, you’ll help legitimize the industry by informing other consumers which products are good and which ones they should stay away from.
You’ll also help businesses learn more about what
their customers want. In order for companies to know what to change or improve
about their products, they need feedback from honest product reviewers like
yourselves. And this is where your valued thoughts come into play. No matter
how big or small the praise or critique may be, your opinion matters to the
We are currently recruiting
more testers from Europe. If accepted into the program, you will receive your
first products within a few weeks. After using the product for short period of
time, we require that you write a quick review and there you have it! That’s
all you need to do.
It’s super easy and convenient, and it’s a great way
to save money and learn about new products, while of course, making the CBD
industry a better place for everyone involved.
All communication with our testers will be done via
email, so please subscribe to the CBD Deals Weekly where we will share
important updates, invitations to review products, and exclusive offers on
items that have already received great reviews.
Don’t forget to sign up ASAP before all the spots are filled. We look forward to learning more about products with you!
The small South American nation of Uruguay was the
first to legalize marijuana for adults. New Zealand, Luxembourg and
Mexico are among those that have looked to Canada for guidance or
lessons, while Russia has chastised it for its “barefaced” flouting of
international anti-drug treaties.
Here’s a look at how Canada’s experiment is playing out internationally and where the next attempts at legalization are coming:
continue to flout federal prohibition and legalize marijuana within
their borders, arguing that the nation’s war on pot has drained law
enforcement resources, had a disparate impact on minorities and failed
to curb the drug’s popularity.
Thirty-three states and Washington,
D.C., have now legalized cannabis for medical or recreational use, with
Michigan and Illinois the most recent of 11 states to OK recreational
Last month, the U.S. House of Representatives, with
significant bipartisan support, passed a bill that would grant legal
marijuana businesses access to banking while sheltering financial
institutions from prosecution for handling marijuana-linked money. That
would clear up a serious headache for the industry. Many pot businesses
have had to conduct sales and pay vendors or taxes in cash, making them
robbery targets and also making it harder to detect theft, tax evasion
and money laundering.
Advocates say the vote was a sign the U.S.,
long the world’s leading proponent of the drug war, is ready for
comprehensive cannabis reform.
small nation of about 615,000 people has decriminalized possession of
small amounts of the drug, and since January it has allowed medical use.
Now it is aiming to become the first country in Europe to legalize and
regulate recreational sales to adults, a development that could lead to
broader cannabis regulation in the European Union.
has announced that it intends to legalize sales, with Health Minister
Etienne Schneider recently telling the Euronews television network that
the country’s cannabis legislation will be “inspired by the Canadian
model.” Officials estimate that it will take about two years before
legal sales begin.
While Schneider said Luxembourg’s legalization
won’t force the hand of other EU nations, he said he intended to speak
with counterparts in Germany, France and Belgium, the countries that
border Luxembourg, and encourage them to explore the possibility of
regulating the drug. In the meantime, Schneider said, Luxembourg will
respect their prohibitions by limiting sales to Luxembourg residents.
Supreme Court ruled last year that the government’s ban on the personal
use of marijuana was unconstitutional, the culmination of a series of
rulings against prohibition since 2015. That’s helped put Mexico on a
path toward full legalization. Before he was even sworn in, President
Andrés Manuel López Obrador sent emissaries to Canada to discuss its
approach to cannabis.
Things are moving quickly now, with the
ruling party’s Senate leader saying the chamber intends to vote on a new
legalization measure by the end of this month, following dozens of
forums in which politicians, advocates and voters have worked out what a
regulated system might look like.
“The importance of Canada
having regulated is that it broke the taboo on an international level in
a way that Uruguay did not,” said Zara Snapp, a drug policy reform
advocate in Mexico City. “For us, what it taught us is there is a path,
and that path is possible without there being any apocalyptic sanctions
from international bodies.”
That said, after severe drug-war
violence, Mexico’s legalization is not likely to mirror Canada’s, where a
few massive corporations have dominated production and more artisanal
growers have largely been shut out. For example, lawmakers are
considering giving greater licensing privileges to indigenous groups,
“We need it to have a way bigger impact than just tax
revenue or stock exchange values,” Snapp said. “The things that indicate
success in other jurisdictions are not going to be the same indicators
of success for us.”
New Zealand will
hold a referendum next year on whether to legalize and regulate the
adult use of marijuana — the first country to put legalization to a
nationwide vote. Officials are still hammering out the exact language,
but in a speech last month Justice Minister Andrew Little said the
measure would include a minimum purchase and use age of 20; a ban on
using the drug in public; limits on home growing, marketing and
advertising; a public education program; and licensing requirements for
the entire supply chain.
“The approach we are taking is that in
the event of a ‘Yes’ vote in the referendum, it will be necessary to
have a regime that affords maximum control, so that the obvious risks
can be minimized,” Little told a drug policy symposium last month.
the vote will be binding is a matter of dispute. The three parties that
make up New Zealand’s governing coalition have vowed to honor it, but
legislation would be required to effect legalization, and the
center-right party National has not made clear whether it will support
Advocates have expressed concern about social justice in
New Zealand’s legalization efforts as well, suggesting that its model
could strike a balance between Uruguay, where access to cannabis is
tightly controlled at a small number of pharmacies, and the more
commercial approach taken by some Canadian provinces and U.S. states.
legalization hasn’t been uniformly well received. Russia’s
representative to the international Commission on Narcotic Drugs
lamented the “barefaced” and “blatant violation by Canada of its
international obligations” under anti-drug treaties.
real danger that some other countries may follow the example set by
Canada, which would lead to the erosion and even dismantling of the
whole international legal foundation of our fight against narcotic
drugs,” Mikhail Ulyanov said.
As recently as this month, Russia’s
mission to the UN tweeted: ”#Legalization of narcotic drugs, including
cannabis, for recreational purposes constitutes a grave violation of the
But Russia may have ulterior motives in
criticizing Canada, given what many world leaders consider to be its own
flouting of international law in annexing Crimea, among other issues.
“Russia has its reasons for trying to call out a country like Canada on its commitment to international rule of law,” said John Walsh, who monitors global drug policy with the advocacy group Washington Office on Latin America. “They delight in being able to say Canada is athwart its obligations. But I don’t think Russia’s bluster is going to keep other countries from moving forward.”
By Gene Johnson
The post A Look At Cannabis Legislation In Countries Around The World appeared first on High Times.